Lymphoma Treatment Price Comparison in Brussels vs Turkey

Lymphoma Treatment Cost: Belgium, Brussels vs Turkey

Introduction & Clinical Importance

Lymphoma treatment targets cancers of the lymphatic system using chemotherapy, radiotherapy, immunotherapy, or stem cell transplants. Applied for Hodgkin or non-Hodgkin types, it improves survival and quality of life but may cause fatigue, infection risks, or long-term side effects like infertility.

In Belgium, Brussels, high costs and waiting lists (months for public care) challenge access, especially uninsured patients. Turkey excels in medical tourism with JCI-accredited centers, high case volumes, and affordable, timely care.

Price Comparison: Belgium, Brussels vs Turkey

Belgium, Brussels: €18,000–€30,000+ (Europe avg.); higher in private/insured cases.
Turkey: $10,000–$75,000 (€8,000–€15,000 for basics like chemo cycles), including consultation, tests, treatment, 2-3 day stay, meds.

Save 40-70% in Turkey due to lower operational costs.

Turkey’s Price Advantage & Superiorities

Turkey’s favorable exchange rates, competitive market, and high oncology volume (thousands annually) enable savings. Medical tourists enjoy short flights from Europe, visa ease for many, English/Arabic/Russian support, and packages with transfers/hotels.

Treatment Options, Modalities & Technologies

Main options: R-CHOP chemo ($15,000–$25,000/6 cycles), radiotherapy ($4,000–$7,000), CAR-T ($50,000–$70,000), transplants ($35,000–$120,000). Turkey’s PET-CT, robotic systems match Belgium’s standards; Brussels offers similar but with limited public access.

Treatment Process: Patient Journey Comparison

Turkey: Online eval, quick tests, arrival-procedure-discharge in days; coordinators, interpreters, transfers included.
Belgium, Brussels: Delays from waits, insurance approvals.

Turkey organizes 2-4x faster.

Quality Assurance & Long-Term Follow-up

JCI/ISO-accredited Turkish centers feature trained oncologists (5+ years specialized), multidisciplinary teams, strict infection protocols. Follow-up via teleconsultation; reports compatible for Brussels physicians. Risks like complications exist—personalized quotes advised as prices vary by condition.